Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06192797
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT05655949
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +14 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT03364530
- Conditions
- Cholangiocarcinoma Non-resectable, Non-metastatic
- Locations
-
- Amiens University Hospital Amiens, France
- Angers University Hospital Angers, France
- Bordeaux University Hospital Bordeaux, France
- Centre Georges François Leclerc Dijon, France
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Oslo University Hospital Oslo, Norway
NCT06487663
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Enrolling by Invitation
Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction
NCT06671418
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Cholangiocarcinoma Non-resectable, +9 more
- Locations
-
- Erasmus MC Rotterdam, Netherlands
Not Yet Recruiting
TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort
NCT07454486
- Conditions
- Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), +28 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
Not Yet Recruiting
Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma
NCT07326189
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
Not specified
NCT03377179
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +8 more
- Locations
-
- Mayo Clinic Cancer Center Phoenix, Arizona, United States
- Emory University Atlanta, Georgia, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT04860154
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Southwest Hospital, Army Medical University Chongqing, Chongqing Municipality, China
- The First Hospital of Lanzhou University Lanzhou, Gansu, China
- The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT03473574
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
- Locations
-
- Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie & Endokrinologie Hanover, Germany
NCT03043547
- Conditions
- Cholangiocarcinoma Advanced, Cholangiocarcinoma Metastatic, Cholangiocarcinoma Non-resectable, +1 more
- Locations
-
- Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover Hanover, Germany
Active, Not Recruiting
A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
NCT06081829
- Conditions
- Cholangiocarcinoma Metastatic, Cholangiocarcinoma Non-resectable
- Locations
-
- National Cancer Center Hospital East (JPN-002) Kashiwa, Japan
- Kumamoto University Hospital (JPN-004) Kumamoto, Japan
- National Hospital Organization Shikoku Cancer Center (JPN-007) Matsuyama, Japan
- Osaka International Cancer Institute (JPN-005) Osaka, Japan